Risk factors for neural tube defects: Associations between uncoupling protein 2 polymorphisms and spina bifida

Birth Defects Research Part A - Clinical and Molecular Teratology

Volumn 67, Issue 3, 2003, Pages 158-161

  Volcik, Kelly A ^a   Shaw, Gary M ^b   Zhu, Huiping ^a   Lammer, Edward J ^c   Finnell, Richard H ^a  

^a TEXAS A AND M HEALTH SCIENCE CENTER   (United States)

^b California Birth Defects Monitoring Program   (United States)

^c CHILDREN S HOSPITAL OAKLAND   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; AMINO ACID; DNA BASE; UNCOUPLING PROTEIN 2; VALINE;

3' UNTRANSLATED REGION; AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ARTICLE; BASE MISPAIRING; BLOOD SAMPLING; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; EXON; GENE DELETION; GENE FREQUENCY; GENE INSERTION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC VARIABILITY; HOMOZYGOTE; HUMAN; INFANT; MAJOR CLINICAL STUDY; NEURAL TUBE DEFECT; NEWBORN SCREENING; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION MAPPING; RISK ASSESSMENT; RISK FACTOR; SPINA BIFIDA;

CALIFORNIA; CASE-CONTROL STUDIES; DNA; FEMALE; GENE DELETION; GENETIC PREDISPOSITION TO DISEASE; GENOME, HUMAN; GENOTYPE; HUMANS; INFANT, NEWBORN; ION CHANNELS; MEMBRANE TRANSPORT PROTEINS; MITOCHONDRIAL PROTEINS; ODDS RATIO; POINT MUTATION; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; PREGNANCY; PROTEINS; RISK FACTORS; SPINAL DYSRAPHISM;

INSERTION SEQUENCES; TRIXIS;

EID: 0141995058     PISSN: 15420752     EISSN: None     Source Type: Journal    
DOI: 10.1002/bdra.10019     Document Type: Article

References (39)

1. Becerra JE, Khoury MJ, Cordero JF, Erickson JD. 1990. Diabetes mellitus during pregnancy and the risks for the specific birth defects: a population-based case-control study. Pediatrics 85:1-9.
2. Boss O, Samec S, Paoloni-Giacobino A, Rossier C, Dulloo A, Seydoux J, Muzzin P, Giacobino JP. 1997. Uncoupling protein-3: a new member of the mitochondrial carrier family with tissue-specific expression. FEBS Lett 408:39-42.
3. Cassell PG, Neverova M, Janmohamed S, Uwakwe N, Qureshi A, McCarthy MI, Saker PJ, Albon L, Kopelman P, Noonan K, Easlick J, Ramachandran A, Snehalatha C, Pecqueur C, Ricquier D, Warden C, Hitman GA. 1999. An uncoupling protein 2 gene variant is associated with a raised body mass index but not Type II diabetes. Diabetologia 42:688-692.
4. Croen LA, Shaw GM, Jensvold NG, Harris JA. 1991. Birth defects monitoring in California: a resource for epidemiological research. Paediatr Perinat Epidemiol 5:423-427.
5. Dalgaard LT, Pedersen O. 2001. Uncoupling proteins: functional characteristics and role in the pathogenesis of obesity and Type II diabetes. Diabetologia 44:946-965.
6. Eriksson UJ, Borg LAH. 1991. Protection by free oxygen radical scavenging enzymes against glucose-induced embryonic malformations in vitro. Diabetologia 34:325-331.
7. Eriksson UJ, Siman CM. 1996. Pregnant diabetic rats fed the antioxidant butylated hydroxytoluene show decreased occurrence of malformations in offspring. Diabetes 45:1497-1502.
8. Fine EL, Horal M, Chang TI, Fortin G, Loeken MR. 1999. Evidence that elevated glucose causes altered gene expression, apoptosis, and neural tube defects in a mouse model of diabetic pregnancy. Diabetes 48:2454-2462.
9. Fleury C, Neverova M, Collins S, Raimbault S, Champigny O, Levi-Meyrueis C, Bouillaud F, Seldin MF, Surwit RS, Ricquier D, Warden C. 1997. Uncoupling protein-2: a novel gene linked to obesity and hyperinsulinemia. Nat Genet 15:269-272.
10. Gong DW, He Y, Karas M, Reitman M. 1997. Uncoupling protein-3 is a mediator of thermogenesis regulated by thyroid hormone, beta3-adrenergic agonists, and leptin. J Biol Chem 272:24129-24132.
11. Hagay ZJ, Weiss Y, Zusman I, Peled-Kamar M, Reece EA, Eriksson UJ, Groner Y. 1995. Prevention of diabetes-associated embryopathy by overexpression of the free radical scavenger copper zinc superoxide dismutase in transgenic mouse embryos. Am J Obstet Gynecol 173:1036-1041.
12. Hawthorne G, Robson S, Ryall EA, Sen D, Roberts SH, Ward PMP. 1997. Prospective population based survey of outcome of pregnancy in diabetic women: results of the Northern Diabetic Pregnancy Audit, 1994. BMJ 315:279-281.
13. Kambe F, Nomure Y, Okamot T, Seo H. 1996. Redox regulation of thyroidtranscription factors, Pax-8 and TTF-1, is involved in their increased DNA-binding activities by thyrotropin in rat thyroids FRTL-5 cells. Mol Endocrinol 10:801-812.
14. Kitzmiller JL, Cloherty JP, Younger MD, Tabatibaii A, Rothchild SB, Sosenko I, Epstein MF, Singh S, Neff RK. 1978. Diabetic pregnancy and perinatal morbidity. Am J Obstet Gynecol 131:560-580.
15. Larkin S, Mull E, Miao W, Pittner R, Albrandt K, Moore C, Young A, Denaro M, Beaumont K. 1997. Regulation of the third member of uncoupling protein family, UCP3, by cold and thyroid hormone. Biochem Biophys Res Commun 240:222-227.
16. Lee FY, Li Y, Zhu H, Yang S, Lin HZ, Trush M, Diehl AM. 1999. Tumor necrosis factor increases mitochondrial oxidant production and induces expression of uncoupling protein-2 in the regenerating mice liver. Hepatology 29:677-687.
17. Lentes KU, Tu N, Chen H, Winnikes U, Reinert I, Marmann G, Pirke KM. 1999. Genomic organization and mutational analysis of the human UCP2 gene, a prime candidate gene for human obesity. J Recept Signal Transduct Res 19:229-244.
18. Masaki T, Yoshimatsu H, Kakuma T, Hidaka S, Kurokawa M, Sakata T. 1997. Enhanced expression of uncoupling protein 2 gene in white adipose tissue and skeletal muscle following treatment with thyroid hormone. FEBS Lett 418:323-326.
19. Millet L, Vidal H, Andreelli F, Larrouy D, Riou JP, Ricquier D, Laville M, Langin D. 1997. Increased uncoupling protein-2 and -3 mRNA expression during fasting in obese and lean humans. J Clin Invest 100:2665-2670.
20. Miodovnik M, Mimouni F, Dignan PSJ, Berk MA, Ballard JL, Siddiqi TA, Khoury J, Tsang RC. 1988. Major malformations in infants of IDDM women: vasculopathy and early first-trimester poor glycemic control. Diabetes Care 11:713-718.
21. Otabe S, Clement K, Rich N, Warden C, Pecqueur C, Neverova M, Raimbault S, Guy-Grand B, Basdevant A, Ricquier D, Froguel P, Vasseur F. 1998. Mutation screening of the human UCP2 gene in normoglycemic and NIDDM morbidly obese patients: lack of association between new UCP2 polymorphisms and obesity in French Caucasians. Diabetes 47:840-842.
22. Schrauwen P, Walder K, Ravussin E. 1999. Human uncoupling proteins and obesity. Obes Res 7:97-105.
23. Schwartz EI, Khalchitsky SE, Eisensmith RC, Woo SL. 1990. Polymerase chain reaction amplification from dried blood spots on Guthrie cards. Lancet 336:639-640.
24. Shaw GM, Rozen R, Finnell RH, Wasserman CR, Lammer EJ. 1998. Maternal vitamin use, genetic variations of infant methylenetetrahydrofolate reductase and risk for spina bifida. Am J Epidemiol 148:30-37.
25. Shaw GM, Schaffer D, Velie EM, Morland K, Harris JA. 1995. Periconceptional vitamin use, dietary folate, and the occurrence of neural tube defects. Epidemiology 6:219-226.
26. Shaw GM, Todoroff K, Finnell RH, Lammer EJ. 2000. Spina bifida phehotypes in infants or fetuses of obese mothers. Teratology 61:376-381.
27. Shaw GM, Velie EM, Schaffer D. 1996. Risk of neural tube defect-affected pregnancies among obese women. JAMA 275:1093-1096.
28. Shiinoki T, Suehiro T, Ikeda, Y, Inoue M, Nakamura T, Kumon Y, Nakauchi Y, Hashimoto K. 1999. Screening for variants of the uncoupling protein 2 gene in Japanese patients with non-insulin dependent diabetes mellitus. Metabolism 48:581-58
29. Sivan E, Reece EA, Wu Y-K, Homko CJ, Polansky M, Borenstein M. 1996. Dietary vitamin E prophylaxis and diabetic embryopathy: morphologic and biochemical analysis. Am J Obstet Gynecol 175:793-799.
30. Walder K, Norman RA, Hanson RL, Schrauwen P, Neverova M, Jenkinson CP, Easlick J, Warden CH, Pecqueur C, Raimbault S, Ricquier D, Harper M, Silver K, Shuldiner AR, Solanes G, Lowell BB, Chung WK, Leibel RL, Pratley R, Ravussin E. 1998. Association between uncoupling protein polymorphisms (UCP2-UCP3) and energy metabolism/obesity in Pima Indians. Hum Mol Genet 7:1431-1435.
31. Waller DK, Mills JL, Simpson JL, Cunningham GC, Conley MR, Lassman MR, Rhoads GG. 1994. Are obese women at higher risk for producing malformed offspring? Am J Obstet Gynecol 170:541-548.
32. Warden C. 1999. Genetics of uncoupling proteins in humans. International Journal of Obesity 23(Suppl):546-548.
33. Wasserman CR, Shaw GM, O'Malley CD, Tolarova MM, Lammer EJ. 1996. Parental cigarette smoking and risk for congenital anomalies of the heart, neural tube, or limb. Teratology 53:261-267.
34. Watkins ML, Scarlon KS, Mulinare J, Khoury MJ. 1996. Is maternal obesity a risk factor for anencephaly and spina bifida? Epidemiology 7:507-512.
35. Weigle DS, Selfreidge LE, Schwartz MW, Seeley RJ, Cummings DE, Havel PJ, Kuijper JL, Bertran del Rio H. 1998. Elevated free fatty acids induce uncoupling protein 3 expression in muscle: a potential explanation for the effect of fasting. Diabetes 47:298-302:
36. Wentzel P, Thunberg L, Eriksson UJ. 1997. The teratogenic effect of diabetic serum is prevented by supplementation of superoxide dismutase and N-acetylcysteine in rat embryo culture. Diabetologia 40:7-14.
37. Werler MM, Louik C, Shapiro S, Mitchell AA. 1996. Pre-pregnant weight in relation to risk of neural tube defects. JAMA 275:1089-1092.
38. Wu X, Bishopric NH, Discher DJ, Murphy BJ, Webster KA. 1996. Physical and functional sensitivity of zinc finger transcription factors to redox change. Mol Cell Biol 16:1035-1046.
39. Yanovski JA, Diament AL, Sovik KN, Nguyen TT, Li H, Sebring NG, Warden CH. 2000. Associations between uncoupling protein 2, body composition, and resting energy expenditure in lean and obese African American, white, and Asian children. Am J Clin Nutr 71:1405-1412.